Annotation Detail for MYBPC3

Basic Information
Top
Pathway ID | Pathway Name |
---|
hsa05410 | Hypertrophic cardiomyopathy (HCM) |
hsa05414 | Dilated cardiomyopathy |
Pathway ID | Pathway Name |
---|
| Muscle contraction |
Desease ID | Desease Name |
---|
| Circulatory system diseases |
| Cardiac diseases |
H00294 | Dilated cardiomyopathy (DCM) |
H00292 | Hypertrophic cardiomyopathy (HCM) |
Desease ID | Desease Name |
---|
2075 | Heart failure |
Desease Name |
---|
CARDIOVASCULAR |
cardiomyopathy |
familial hypertrophic cardiomyopathy. |
Desease Name |
---|
Cardiomyopathy, familial hypertrophic, 4 |
Cardiomyopathy, dilated |
Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D018038 |
Sodium Selenite |
Sodium Selenite results in decreased expression of MYBPC3 mRNA | decreases expression | 18175754
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D009202 |
Cardiomyopathies |
marker/mechanism |
|
| 19151713 |
MESH:D002311 |
Cardiomyopathy, Dilated |
marker/mechanism |
|
| |
OMIM:115197 |
CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 4 |
marker/mechanism |
|
| |
MESH:D019457 |
Chromosome Breakage |
|
Sodium Selenite |
5.66 | 15894690 |
MESH:D016757 |
Death, Sudden, Cardiac |
marker/mechanism |
|
| 20435227 |
MESH:D003920 |
Diabetes Mellitus |
|
Sodium Selenite |
4.30 | 16285004 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Sodium Selenite |
2.39 | 15131321 |
MESH:D007333 |
Insulin Resistance |
|
Sodium Selenite |
3.60 | 14714311 |
MESH:D016393 |
Lymphoma, B-Cell |
|
Sodium Selenite |
4.76 | 14737004 |
MESH:D011471 |
Prostatic Neoplasms |
|
Sodium Selenite |
3.32 | 18760546 |
PharmGKB Accession:PA31351
Releated disease ID |
Related disease Name |
PA445018 | Cardiomyopathies |